“Absolutely LOVED this course. I liked that we got to review audio and video recordings of patients together. She really highlighted key characteristics of each type of dysarthria that have confused me all these years. I'm super excited to use these skills and motivated to learn more to better serve my patients!”
“This was a great course for anyone who assesses and treats patients with Motor Speech Disorders. The presenter thoroughly went through each topic, explained different types of dysarthria and their neuro connection, provided different assessment tools, and even touched on treatment. This course increased my confidence in this area of SLP.” – G.J.
“Kaila was very open about her research, bias, and opinion. The examples used were so helpful to connect perceptual characteristics to diagnosis. I was totally picturing previous patients and saying “that’s what they sounded like!!!”
Motor Speech Disorders for the Medical Speech-Language Pathologist
In this course, learners will:
- Outline the importance of assessing and managing motor speech disorders in a medical setting.
- Describe, implement, and interpret a short protocol for the assessment of motor speech disorders.
- Summarize management techniques appropriate for patients in a medical setting.
Kaila Stipancic is currently a postdoctoral researcher in the UB Motor Speech Disorders Lab at the University at Buffalo. She received her BA in Speech and Language Sciences at Brock University in Ontario, Canada, her MA in Communicative Disorders and Sciences at the University at Buffalo, and her Ph.D. in Rehabilitation Sciences at the MGH Institute of Health Professions in Boston, MA. She completed her clinical fellowship in speech-language pathology at the University of Wisconsin-Madison in an acute-care setting. Broadly, she is interested in how the brain controls the muscles of speech and swallowing and the perceptual, acoustic, kinematic, and neurophysiologic consequences of neurodegenerative disease on these functions. She has a particular interest in the measurement of relevant clinical outcomes, such as speech intelligibility, and in improving therapeutic options to improve the quality of life of patients with oromotor impairments.